Literature DB >> 18712734

Long-term population-based risks of breast cancer after childhood cancer.

Raoul C Reulen1, Aliki J Taylor, David L Winter, Charles A Stiller, Clare Frobisher, Emma R Lancashire, Fabienne M McClanahan, Elaine M Sugden, Mike M Hawkins.   

Abstract

Previous studies have reported substantially increased risks of breast cancer among survivors of childhood cancer at 10-20 years posttreatment. Whether these excess risks are sustained beyond 40 years of age when general population incidence of breast cancer begins its steep increase is largely unknown. We quantified the risk of breast cancer in adult female survivors with considerably more survivors followed-up beyond 40 years of age than previously available. Standardized Incidence Ratios (SIR), Excess Absolute Risks (EAR), and cumulative incidence were calculated within a population-based cohort of 8,093 female survivors of childhood cancer. Poisson regression models were used to model SIRs and EARs in a multivariable setting. Eighty-one survivors developed a primary breast cancer, where 37.5 were expected (SIR= 2.2, 95% CI: 1.7-2.7). SIRs decreased significantly with increasing attained age (p(trend) < 0.001) to an SIR of 0.9 (95% CI: 0.5-1.8) at ages beyond 50 years; EARs increased significantly to about 40 years of age (p(trend) < 0.001) but then plateau. Between 30 and 49 years of age survivors experienced approximately 1 extra breast cancer per 1,000 survivors per year. Overall, 3% developed breast cancer by the age of 50. The substantially increased relative risks of breast cancer observed at 10-20 years postdiagnosis are not sustained into ages at which the risk of breast cancer in the general population becomes substantial. Among women who survived to an age of at least 50 years there is currently no evidence of an increased risk of breast cancer. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18712734     DOI: 10.1002/ijc.23743

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Measuring childhood cancer late effects: evidence of a healthy survivor effect.

Authors:  Peter Haubjerg Asdahl; Rohit Priyadarshi Ojha; Jeanette Falck Winther; Anna Sällfors Holmqvist; Sofie de Fine Licht; Thorgerdur Gudmundsdottir; Laura Madanat-Harjuoja; Laufey Tryggvadottir; Klaus Kaae Andersen; Henrik Hasle
Journal:  Eur J Epidemiol       Date:  2017-11-28       Impact factor: 8.082

2.  Cohort Profile: the French childhood cancer survivor study for leukaemia (LEA Cohort).

Authors:  Julie Berbis; Gérard Michel; André Baruchel; Yves Bertrand; Pascal Chastagner; François Demeocq; Justyna Kanold; Guy Leverger; Dominique Plantaz; Marilyne Poirée; Jean-Louis Stephan; Pascal Auquier; Audrey Contet; Jean-Hugues Dalle; Stéphane Ducassou; Virginie Gandemer; Patrick Lutz; Nicolas Sirvent; Marie-Dominique Tabone; Sandrine Thouvenin-Doulet
Journal:  Int J Epidemiol       Date:  2014-03-17       Impact factor: 7.196

Review 3.  Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma.

Authors:  Emily S Tonorezos; Danielle Novetsky Friedman; Dana Barnea; Machteld I Bosscha; Guillermo Chantada; Charlotte J Dommering; Pim de Graaf; Ira J Dunkel; Armida W M Fabius; Jasmine H Francis; Mary-Louise C Greer; Ruth A Kleinerman; Wijnanda A Kors; Suzanne Laughlin; Annette C Moll; Lindsay M Morton; Petra Temming; Margaret A Tucker; Flora E van Leeuwen; Michael F Walsh; Kevin C Oeffinger; David H Abramson
Journal:  Ophthalmology       Date:  2020-05-15       Impact factor: 12.079

4.  Breast cancer in female survivors of Wilms tumor: a report from the national Wilms tumor late effects study.

Authors:  Jane M Lange; Janice R Takashima; Susan M Peterson; John A Kalapurakal; Daniel M Green; Norman E Breslow
Journal:  Cancer       Date:  2014-10-27       Impact factor: 6.860

5.  Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan.

Authors:  Yasushi Ishida; Dongmei Qiu; Miho Maeda; Junichiro Fujimoto; Hisato Kigasawa; Ryoji Kobayashi; Maho Sato; Jun Okamura; Shinji Yoshinaga; Takeshi Rikiishi; Hiroyuki Shichino; Chikako Kiyotani; Kazuko Kudo; Keiko Asami; Hiroki Hori; Hiroshi Kawaguchi; Hiroko Inada; Souichi Adachi; Atsushi Manabe; Tatsuo Kuroda
Journal:  Int J Clin Oncol       Date:  2015-11-30       Impact factor: 3.402

6.  Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study.

Authors:  Tara O Henderson; Chaya S Moskowitz; Joanne F Chou; Angela R Bradbury; Joseph Phillip Neglia; Chau T Dang; Kenan Onel; Danielle Novetsky Friedman; Smita Bhatia; Louise C Strong; Marilyn Stovall; Lisa B Kenney; Dana Barnea; Elena Lorenzi; Sue Hammond; Wendy M Leisenring; Leslie L Robison; Gregory T Armstrong; Lisa R Diller; Kevin C Oeffinger
Journal:  J Clin Oncol       Date:  2015-12-23       Impact factor: 44.544

7.  Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study.

Authors:  M P Little; M L Schaeffer; R C Reulen; D H Abramson; M Stovall; R Weathers; F de Vathaire; I Diallo; J M Seddon; M M Hawkins; M A Tucker; R A Kleinerman
Journal:  Br J Cancer       Date:  2014-04-22       Impact factor: 7.640

8.  Proton-beam therapy: are physicists ignoring clinical realities?

Authors:  Michael D Mills; Robert J Schulz
Journal:  J Appl Clin Med Phys       Date:  2015-05-08       Impact factor: 2.102

9.  The effect of patient characteristics on second primary cancer risk in France.

Authors:  Jérémie Jégu; Marc Colonna; Laetitia Daubisse-Marliac; Brigitte Trétarre; Olivier Ganry; Anne-Valérie Guizard; Simona Bara; Xavier Troussard; Véronique Bouvier; Anne-Sophie Woronoff; Michel Velten
Journal:  BMC Cancer       Date:  2014-02-15       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.